To receive the latest news and developments in clinical diagnostics, scientific breakthroughs, and pharma drug discovery and development in the rare and neurodegenerative disease field, please click "subscribe". After that, you will receive an email with a confirmation link. Once you have clicked on that link, we will send you regular updates on what’s happening at CENTOGENE, including, but not limited to, commercial products, services, and upcoming events.
You can unsubscribe from the newsletter with effect for the future at any time using the unsubscribe link at the bottom of every newsletter.
